Kardigan · 1 day ago
Sr. Manager, Clinical Trial Lead
Kardigan is a heart health company focused on making cardiovascular disease preventable and curable. They are seeking a Sr. Manager, Clinical Trial Lead to manage cardiovascular clinical studies, ensuring project deliverables are met according to budget, timelines, and quality standards.
Artificial Intelligence (AI)BiopharmaHealth CareMedical
Responsibilities
Lead the planning, execution, and delivery of assigned clinical trials (global or regional scope)
Drive study timelines, milestones, and deliverables from synopsis through Clinical Study Report
Serve as the primary operational point of contact for the cross-functional study team
Align team execution with the study’s regulatory submission strategy and overall development plan
Oversee site feasibility, selection, initiation, and activation; delegate to Clinical Trial Managers (CTMs) as appropriate
Partner with CTMs to ensure vendor and site readiness across start-up, enrollment, monitoring, and closeout
In partnership with the COPL, develop and execute participant recruitment strategies; review and approve operational plans, study manuals, and charters
Lead operational strategy related to drug supply, remote monitoring, and decentralized trial processes
Collaborate closely with the Clinical Development Lead on protocol development, amendments, and master ICFs
Liaise with cross-functional team representatives to ensure cohesive trial execution
Provide input into CRO and vendor selection, ensuring alignment with trial needs and operational strategy
Direct and manage CRO and vendor partnerships, holding them accountable for timelines, quality, and budget commitments
Drive management of CROs, vendors, and external partners through oversight, escalation, and proactive issue resolution
Contribute to initial trial budget development and ongoing financial oversight
Review and approve CRO/vendor work orders and change orders for accuracy and completeness
Ensure compliance with ICH-GCP, local regulations, and company SOPs
Oversee and coordinate the review of protocol deviations; manage amendments with cross-functional alignment
Partner with Data Management to develop and approve data cleaning plans
Maintain decision, action, and risk logs; escalate issues proactively and implement CAPAs when required
Contribute to inspection readiness and support audits and regulatory inspections
Coordinate responses to health authorities, ethics committees, and IRBs as needed
Review and contribute to clinical study reports and regulatory filings
May directly manage Clinical Trial Associates (CTAs), Clinical Trial Managers (CTMs), or other assigned staff (e.g. contingent workers)
Provide coaching, feedback, and performance management to direct reports
Support career development and training to build functional and leadership capabilities within the team
Lead by example, fostering a collaborative and high-performance culture
Qualification
Required
Minimum of BA/BS with approximately 10 years of experience in global clinical trial management roles from pharmaceutical companies and/or CROs
Experience in early and late phase drug development; some late-stage development experience is required
Multi-dimensional Clinical Operations background with capability of devising plans for operational challenges such as site activation, subject enrollment, monitoring oversight, protocol deviation management, data cleaning, etc
Excellent communication skills, both verbal and written
Demonstrated ability to lead & collaborate with cross-functional teams to drive operational excellence
Confidence to challenge status-quo thinking and behavior
Can work with agility and an innovative mindset
Experience in ICH/GCP inspections, audits and inspection preparedness
Experience in mentoring Clinical Operations staff
Preferred
Advanced degree preferred
Experience within the field of cardiovascular studies and/or rare disease is desirable
Company
Kardigan
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Funding
Current Stage
Growth StageTotal Funding
$554M2025-10-14Series B· $254M
2025-01-10Series A· $300M
Recent News
2025-12-16
2025-11-19
Company data provided by crunchbase